F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

The Food and Drug Administration has announced that it was revoking its approval of the drug Avastin for breast cancer after concluding that it “has not been shown to be safe and effective for that use.”
Avastin, made by the pharmaceutical company Roche, will remain an approved treatment for certain types of colon, lung, kidney and brain cancer, the F.D.A. commissioner, Margaret A. Hamburg, announced.
Full FDA Press Announcement

About The Author

Laura Hack

Laura Hack

Laura Hack is a paralegal with Terrell • Hogan. She has been with the firm since 1996 and has worked primarily for Wayne Hogan. She is an experienced Paralegal with 30+ years of working in the law practice industry. Skilled in Appeals, Civil Trial Litigation Support, Torts, Trial Practice, and Pleadings.